Company Announcements
| Date | Title | Download |
|---|---|---|
| 05/03/10 | Appendix 3B | Download |
| 05/03/10 | Lapse of Unlisted Share Options | Download |
| 24/02/10 | Clinuvel hosts 2nd Annual Scientific & Clinical Excellence Meeting (ASCEM II) | Download |
| 10/02/10 | Clinuvel announces strategic focus of final regulatory program | Download |
| 08/02/10 | Clinuvel Newsletter - February 2010 | Download |
| 05/02/10 | Appendix 4D - Half Yearly Report | Download |
| 29/01/10 | Appendix 4C | Download |
| 14/01/10 | Appendix 3B | Download |
| 14/01/10 | Lapse of Unlisted Share Options | Download |
| 21/12/09 | Zwischenergebnisse in Clinuvel`s Phase III Porphyrie Studie | Download |
| 21/12/09 | Preliminary results in Clinuvel’s Phase III porphyria trial | Download |
| 18/12/09 | Clinuvel announces PLE Phase III preliminary results | Download |
| 17/12/09 | FDA grants Clinuvel an additional orphan drug designation | Download |
| 09/12/09 | Medikament verbessert Lebensqualität bei Krebspatienten, Clinuvel bestärkt sein Filing Dossier | Download |
| 09/12/09 | Media Release: Drug improves quality of life in cancer patients | Download |
| 09/12/09 | Afamelanotide improved quality of life in cancer patients | Download |
| 30/11/09 | The European Medicines Agency grants Clinuvel SME status | Download |
| 26/11/09 | Appendix 3Y | Download |
| 18/11/09 | Results of Meeting | Download |
| 18/11/09 | Clinuvel AGM 2009 Chair and CEO Presentation | Download |
| 10/11/09 | Open Briefing. Clinuvel. CEO on MAA application to EMEA | Download |
| 04/11/09 | Expiry of Unlisted Share Options | Download |
| 30/10/09 | Clinuvel Newsletter - October 2009 | Download |
| 28/10/09 | Appendix 4C | Download |
| 23/10/09 | Appendix 3B | Download |
| 16/10/09 | Annual Report to shareholders | Download |
| 16/10/09 | Notice of Meeting and Proxy Form | Download |
| 16/10/09 | Conditional Performance Rights Plan | Download |
| 25/09/09 | Financial Report Year Ended 30 June 2009 | Download |
| 11/09/09 | CEO Presentation - Rodman and Renshaw Healthcare Conference. | Download |
| 31/08/09 | Confirmatory Phase III EPP trial receives approval. | Download |
| 27/08/09 | Preliminary final report | Download |
| 25/08/09 | Open Briefing. Clinuvel. CEO on afamelanotide commercialisation. | Download |
| 25/08/09 | Clinuvel Afamelanotide Commercialisation Presentation - August 2009 | Download |
| 07/08/09 | Appendix 3Y | Download |
| 31/07/09 | Clinuvel Newsletter - July 2009 | Download |
| 31/07/09 | Appendix 4C | Download |
| 15/07/09 | Technical Note: Phase II Solar Urticaria study | Download |
| 15/07/09 | Clinuvel announces positive results in Phase II Solar Urticaria study | Download |
| 23/06/09 | Lapse and Expiry of Unlisted Share Options | Download |
| 18/06/09 | EMEA grants Clinuvel new orphan drug designation | Download |
| 18/05/09 | May 2009 European Roadshow Presentation | Download |
| 30/04/09 | Appendix 4C | Download |
| 23/04/09 | Response to an ASX Price Query | Download |
| 16/04/09 | Open Briefing. Clinuvel. Revenue Prospects and Strategy | Download |
| 14/04/09 | Clinuvel Newsletter - April 2009 | Download |
| 18/03/09 | Clinuvel Corporate Presentation - March 2009 | Download |
| 26/02/09 | Clinuvel Newsletter - February 2009 | Download |
| 30/01/09 | Appendix 4C | Download |
| 29/01/09 | FDA allows IND status for Clinuvel's afamelanotide | Download |
| 29/01/09 |
Media Release: FDA allows IND status for Clinuvel's afamelanotide UV- und Lichtschutzwirkstoff Afamelanotide jetzt auch für US-Testreihe zugelassen |
|
| 29/01/09 | Open Briefing. Clinuvel. FDA grants IND status | Download |
| 21/01/09 | Clinuvel announces positive Phase III interim results for EPP | Download |
| 21/01/09 |
Media Release: Clinuvel: positive interim Phase III results for unique skin protection drug Lichtschutzmedikament Afamelanotide in letzter Phase vor Marktzulassung |
|
| 31/12/08 | Clinuvel Newsletter - December 2008 | Download |
| 23/12/08 | Open Briefing. Clinuvel. Submission of IND Application | Download |
| 23/12/08 | Clinuvel lodges IND in US | Download |
| 20/11/08 | Appendix 3Y - Change in Director's interest | Download |
| 19/11/08 | Appendix 3B | Download |
| 13/11/08 | 2008 CEO AGM Presentation | Download |
| 13/11/08 | 2008 CSO AGM Presentation | Download |
| 13/11/08 | 2008 AGM Results of Meeting | Download |
| 31/10/08 | Appendix 4C | Download |
| 13/10/08 | Annual Report 2008 | Download |
| 13/10/08 | Notice of Meeting and Proxy form | Download |
| 03/10/08 | Clinuvel Newsletter - October 2008 | Download |
| 30/09/08 | Financial Report Year Ended 30 June 2008 | Download |
| 23/09/08 | Clinuvel commences Phase II trial in Photodynamic Therapy | Download |
| 10/09/08 | Amended Becoming a substantial holder notice (ASX online) | Download |
| 05/09/08 | Becoming a substantial holder (ASX online) | Download |
| 04/09/08 | Ceasing to be a substantial holder (ASX online) | Download |
| 04/09/08 | Ceasing to be a substantial holder (ASX online) | Download |
| 02/09/08 | International and Australian investors buyout substantial shareholder | Download |
| 29/08/08 | Appendix 4E | Download |
| 01/08/08 | Open Briefing. Clinuvel. FDA Orphan Drug Designation Approval | Download |
| 31/07/08 | Appendix 4C | Download |
| 29/07/08 | FDA grants Clinuvel orphan-drug designation | Download |
| 28/07/08 | Open Briefing. Clinuvel. Strategy & Clinical Program Update | Download |
| 14/07/08 | Appendix 3X - Initial Director's Interest Notice | Download |
| 08/07/08 | New Non-Executive Director | Download |
| 02/07/08 | Appendix 3B | Download |
| 01/07/08 | Clinuvel Newsletter - July 2008 | Download |
| 17/06/08 | World Health Organisation Assigns CUV1647 Generic Name | Download |
| 11/06/08 | Corporate Presentation - FINSIA Lifesciences Showcase | Download |
| 11/06/08 | Clinuvel receives approval to begin Phase II Trials in Solar Urticaria | Download |
| 30/04/08 | Appendix 4C | Download |
| 28/04/08 | Swissmedic grants Clinuvel Orphan Drug Status for CUV1647 | Download |
| 23/04/08 | Clinuvel's latest pharmacokinetic studies further validate human safety of CUV1647 | Download |
| 19/04/08 | Update Investor Presentation April 2008 | Download |
| 31/03/08 | Clinuvel Newsletter - March 2008 | Download |
| 25/03/08 | Teleconference transcript of Investor Update held 19 March 2008 | Download |
| 14/03/08 | Clinuvel Investor Update via teleconference | Download |
| 13/03/08 | Corporate Briefing on Orphan Medicinal Product Designations | Download |
| 12/03/08 | EMEA grants Clinuvel two orphan drug designations | Download |
| 29/02/08 | Appendix 4D Half Yearly Report | Download |
| 05/02/08 | Appendix 3B | Download |
| 31/01/08 | Appendix 4C | Download |
| 10/01/08 | Response to price query | Download |
| 20/12/07 | Open Briefing Clinuvel CEO on Commercialisation Goals | Download |
| 06/12/07 | Clinuvel Pharmaceuticals Ltd appoints new Chair | Download |
| 27/11/07 | Teleconference transcript of Investor Update held 22 November 2007 | Download |
| 20/11/07 | Clinuvel's second regular investor update via teleconference | Download |
| 16/11/07 | Clinuvel opens Europe office | Download |
| 16/11/07 | AGM 2007 Results of Meeting | Download |
| 16/11/07 | Clinuvel AGM Presentation | Download |
| 31/10/07 | Clinuvel’s drug begins global Phase II skin cancer trials | Download |
| 31/10/07 | Appendix 4C | Download |
| 15/10/07 | Annual Report 2007 | Download |
| 15/10/07 | AGM Notice of Meeting | Download |
| 02/10/07 | Open Briefing 2 October 2007 | Download |
| 27/09/07 | Financial Report Year Ended 30 June 2007 | Download |
| 26/09/07 | Clinuvel Shareholder Update 19 September 2007 Conference Call | Download |
| 25/09/07 | Conference Call and Weblink | Download |
| 24/09/07 | Shareholder Update Repeat Conference Call | Download |
| 20/09/07 | Shareholder Update | Download |
| 19/09/07 | Clinuvel initiates regular investor update via teleconference – Updated contact numbers | Download |
| 07/09/07 | Appendix 3Y | Download |
| 30/08/07 | Amendment to Appendix 4E | Download |
| 29/08/07 | Appendix 4E and Preliminary Financial Report | Download |
| 21/08/07 | Clinuvel Appoints Head of Corporate Development | Download |
| 03/08/07 | Appendix 3B | Download |
| 27/07/07 | Appendix 4C | Download |
| 19/07/07 | Selection of final dosage for development of CUV1647 | Download |
| 10/07/07 | Dr Aston appointed to Goverment Committee | Download |
| 04/07/07 | End of Financial Year Report to Shareholders | Download |
| 03/07/07 | Clinuvel relocates Melbourne office | Download |
| 03/07/07 | Clinuvel Newsletter - Issue No 2 - June 2007 | Download |
| 28/06/07 | Open Briefing®. Clinuvel. Update on Start of Phase III | Download |
| 07/06/07 | Appendix 3Z - Final Director’s Interest Notice | Download |
| 06/06/07 | Appendix 3B - Application for Quotation of Additional Securities | Download |
| 06/06/07 | Phase III trial begins in Erythropoietic Protoporphyria | Download |
| 01/06/07 | Clinuvel Share Purchase Plan completed | Download |
| 01/06/07 | Clinuvel board member resigns | Download |
| 21/05/07 | Phase III trial of CUV1647 begins in Polymorphic Light Eruption | Download |
| 11/05/07 | Clinuvel Share Purchase Plan | Download |
| 10/05/07 | Correction to Appendix 3B – Application for Quotation of Additional Securities | Download |
| 07/05/07 | Appendix 3B - Application for Quotation of Additional Securities | Download |
| 27/04/07 | Appendix 4C March 2007 Quarterly Report | Download |
| 26/04/07 | Clinuvel Completes A$26M Private Placement | Download |
| 23/04/07 | Request for Trading Halt | Download |
| 11/04/07 | Clinuvel receives approval to begin Phase III trials in EPP | Download |
| 03/04/07 | Strategic Update to Investors | Download |
| 26/03/07 | Clinuvel Newsletter - Issue No 1 - March 2007 | Download |
| 20/03/07 | Open Briefing. Clinuvel. CUV1647 Treatment of PDT | Download |
| 20/03/07 | New Oncology application identified for CUV1647 | Download |
| 27/02/07 | Appendix 4D Half Year Report | Download |
| 22/02/07 | Clinuvel reports first positive Phase II clinical trial results of CUV1647 in new indication -EPP | Download |
| 16/02/07 | Appendix 3Y Change of Director's Interest Notice | Download |
| 09/02/07 | Appendix 3B New issue announcement, application for quotation of additional securities | Download |
| 07/02/07 | Appendix 3X Ms Brenda Shanahan | Download |
| 06/02/07 | New Non-Executive Director | Download |
| 31/01/07 | Open Briefing Clinuvel Phase III PLE Trials | Download |
| 31/01/07 | Clinuvel receives medical ethics approval to begin a Phase III trial in the UK | Download |
| 30/01/07 | Appendix 4C December 2006 Quarterly Report | Download |
| 25/01/07 | EGM Results | Download |
| 24/01/07 | Clinuvel receives approval to begin Phase III trials | Download |
| 22/01/07 | Appendix 3B | Download |
| Date | Title | Download |
